Physician

Jenny Paola Rodriguez Alzate, M.D.

According to 2025 Medicare claims, Jenny Alzate, M.D. (NPI: 1831463504) practices neuropsychiatry in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is UNIVERSITY OF PENN-MEDICAL GROUP (NPI: 1821486846; TIN: 232743545) and primary practice location at 19104-3309. Alzate is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033), participating under the MSSP model.

Alzate's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 313 traditional Medicare patients, billed 1,101 HCPCS/CPT codes, and received $69,233 in Medicare payments. The top billing code was 90792 (Psychiatric diagnostic evaluation with medical services). Part D data shows 2,869 prescription claims across 286 beneficiaries totaling $92,755 in drug costs, led by Trintellix (Vortioxetine Hydrobromide). Open Payments data shows 2 records totaling $75. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $30,173 and ending at $69,233. Concurrently, Part D prescription costs have risen steadily, from $40,604 to $92,755. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	74	296	$30,173
2018	204	847	$85,437
2019	141	699	$66,579
2020	184	1,078	$95,098
2021	289	1,154	$89,939
2022	345	1,302	$92,907
2023	322	1,239	$86,891
2024	313	1,101	$69,233

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	43	339	$40,604
2016	16	111	$16,621
2017	74	391	$16,115
2018	93	832	$20,990
2019	104	534	$12,594
2020	138	537	$27,868
2021	218	2,058	$108,200
2022	257	2,800	$125,240
2023	273	2,879	$102,594
2024	286	2,869	$92,755

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90792	Psychiatric diagnostic evaluation with medical services	83	83	$127
90870	Therapy using electrical currents	22	66	$78
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	248	522	$71
90833	Psychotherapy with evaluation and management visit, 30 minutes	133	283	$48
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	101	130	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trintellix	Vortioxetine Hydrobromide	14	514	$8,346
Bupropion Xl	Bupropion Hcl	119	5,992	$5,435
Venlafaxine Hcl Er	Venlafaxine Hcl	317	16,134	$4,960
Mirtazapine	Mirtazapine	231	12,664	$4,730
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	43	1,824	$4,125

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$75	Otsuka Pharmaceutical Development & Commercialization, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jenny Paola Rodriguez Alzate, M.D.?

Tedicare shows public-source Medicare data for Jenny Paola Rodriguez Alzate, M.D. (NPI 1831463504), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jenny Paola Rodriguez Alzate, M.D. have ACO affiliation data?

Jenny Paola Rodriguez Alzate, M.D. is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033).

What billing organization is linked to Jenny Paola Rodriguez Alzate, M.D.?

Jenny Paola Rodriguez Alzate, M.D. is linked to UNIVERSITY OF PENN-MEDICAL GROUP (billing NPI 1821486846) in the available physician profile data.

Does Jenny Paola Rodriguez Alzate, M.D. have Open Payments data?

Jenny Paola Rodriguez Alzate, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.